Skip to main content
Top
Published in: Osteoporosis International 11/2014

01-11-2014 | Original Article

Bone status and fractures in 85 adults with Wilson’s disease

Authors: A.-S. Quemeneur, J.-M. Trocello, H.-K. Ea, A. Ostertag, A. Leyendecker, J.-C. Duclos-Vallée, M.-C. de Vernejoul, F. Woimant, F. Lioté

Published in: Osteoporosis International | Issue 11/2014

Login to get access

Abstract

Summary

Wilson’s disease is characterized by copper deposition, especially in the liver and central nervous system. We assessed the prevalent fractures and bone mineral density (BMD) and related risk factors in 85 patients. BMD was normal, but patients with severe neurological involvement, low BMI, and/or amenorrhea are at risk for fractures.

Introduction

Wilson’s disease (WD) is characterized by copper deposition, especially in the liver and central nervous system. Two studies showed a high prevalence of osteoporosis in WD patients. We wanted to assess the prevalent fractures and bone mineral density (BMD) and to identify risk factors for bone loss and fractures in a large group of WD patients.

Methods

In this prospective cross-sectional survey at National center of reference for WD, we included 85 patients, 47 women, and 38 men, with a mean age of 35 ± 10 years, and mean time from diagnosis to study of 21 ± 9 years; 57 (67 %) patients had neurological signs. Peripheral fractures, prevalent radiological vertebral fractures (VFx), and dual-energy X-ray absorptiometry BMD measurements at the femoral neck (FN) and lumbar spine (LS) were studied.

Results

Mean LS and FN Z-score was normal (−0.37 ± 1.20 at LS and −0.06 ± 1.20 at FN). BMI <19 kg/m2 and amenorrhea were associated with low BMD. Prevalent peripheral fractures were noted in 43 (51 %) and VF in 7 (8 %) patients. Severity of neurological involvement and male sex was associated with peripheral fractures, whereas older age, severe neurological involvement, and low BMD and Z-score values were associated with VF.

Conclusion

Our data showing normal BMD overall do not support routine bone status evaluation in adults with WD. However, patients with severe neurological involvement, low BMI, and/or amenorrhea are at risk factors for fractures and may require specific monitoring.
Literature
1.
go back to reference Trocello JM, Chappuis P, Chaine P, Rémy P, Debray D, Duclos-Vallée JC, Woimant F (2009) Maladie de Wilson. Presse Med 38:1089–1098PubMedCrossRef Trocello JM, Chappuis P, Chaine P, Rémy P, Debray D, Duclos-Vallée JC, Woimant F (2009) Maladie de Wilson. Presse Med 38:1089–1098PubMedCrossRef
2.
go back to reference Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML (2007) Wilson’s disease. Lancet 367:397–408CrossRef Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML (2007) Wilson’s disease. Lancet 367:397–408CrossRef
3.
go back to reference Wiggelinkhuizen M, Tilanus ME, Bollen CW, Houwen RH (2009) Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson’s disease. Aliment Pharmacol Ther 29:947–958PubMedCrossRef Wiggelinkhuizen M, Tilanus ME, Bollen CW, Houwen RH (2009) Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson’s disease. Aliment Pharmacol Ther 29:947–958PubMedCrossRef
4.
go back to reference Kataoka M, Tsumura H, Itonaga I, Kaku N, Torisu T (2004) Subchondral cyst of the tibia secondary to Wilson disease. Clin Rheumatol 23:460–463PubMedCrossRef Kataoka M, Tsumura H, Itonaga I, Kaku N, Torisu T (2004) Subchondral cyst of the tibia secondary to Wilson disease. Clin Rheumatol 23:460–463PubMedCrossRef
5.
go back to reference Kramer U, Weinberger A, Yarom R, Zoldan J, Bahar A, Godoth N (1993) Synovial copper deposition as a possible explanation of arthropathy in Wilson’s disease. Bull Hosp Jt Dis 52:46–49PubMed Kramer U, Weinberger A, Yarom R, Zoldan J, Bahar A, Godoth N (1993) Synovial copper deposition as a possible explanation of arthropathy in Wilson’s disease. Bull Hosp Jt Dis 52:46–49PubMed
6.
go back to reference Menerey KA, Eider W, Brewer GJ, Braunstein EM, Schumacher HR, Fox IH (1988) The arthropathy of Wilson’s disease: clinical and pathologic features. J Rheumatol 15:331–337PubMed Menerey KA, Eider W, Brewer GJ, Braunstein EM, Schumacher HR, Fox IH (1988) The arthropathy of Wilson’s disease: clinical and pathologic features. J Rheumatol 15:331–337PubMed
8.
go back to reference Xie YZ, Zhang XZ, Xu XH, Zhang ZX, Feng YK (1985) Radiologic study of 42 cases of Wilson disease. Skelet Radiol 13:114–119CrossRef Xie YZ, Zhang XZ, Xu XH, Zhang ZX, Feng YK (1985) Radiologic study of 42 cases of Wilson disease. Skelet Radiol 13:114–119CrossRef
9.
go back to reference Canelas HM, Carvalho N, Scaff M, Vitule A, Barbosa ER, Azevedo EM (1978) Osteoarthropathy of hepatolenticular degeneration. Acta Neurol Scand 57:481–487PubMedCrossRef Canelas HM, Carvalho N, Scaff M, Vitule A, Barbosa ER, Azevedo EM (1978) Osteoarthropathy of hepatolenticular degeneration. Acta Neurol Scand 57:481–487PubMedCrossRef
10.
11.
go back to reference Boudin G, Pépin B, Hubault A, Goldstein B, Lidy C (1977) Arthropathies dans la maladie de Wilson. Ann Méd Interne (Paris) 128:853–856 Boudin G, Pépin B, Hubault A, Goldstein B, Lidy C (1977) Arthropathies dans la maladie de Wilson. Ann Méd Interne (Paris) 128:853–856
12.
go back to reference Stavrakakis G, Spengos M, Scarpalezos S (1975) Skeletal mass conversions in hepatolenticular degeneration. Neuroradiology 10:169–172PubMedCrossRef Stavrakakis G, Spengos M, Scarpalezos S (1975) Skeletal mass conversions in hepatolenticular degeneration. Neuroradiology 10:169–172PubMedCrossRef
13.
go back to reference Aksoy M, Camli N, Dilşen G, Koçak N, Erdem S, Ozdogan E, Dinçol K, Dinçol G (1975) Osteoarticular pains and changes in Wilson’s disease: a radiological study in fourteen patients in nine Turkish families. Acta Hepatogastroenterol (Stuttg) 22:164–170 Aksoy M, Camli N, Dilşen G, Koçak N, Erdem S, Ozdogan E, Dinçol K, Dinçol G (1975) Osteoarticular pains and changes in Wilson’s disease: a radiological study in fourteen patients in nine Turkish families. Acta Hepatogastroenterol (Stuttg) 22:164–170
14.
go back to reference Golding DN, Walshe JM (1975) Proceedings: the musculoskeletal features of Wilson’s disease: a clinical, radiological, and serological survey. Ann Rheum Dis 34:201PubMedCrossRefPubMedCentral Golding DN, Walshe JM (1975) Proceedings: the musculoskeletal features of Wilson’s disease: a clinical, radiological, and serological survey. Ann Rheum Dis 34:201PubMedCrossRefPubMedCentral
15.
16.
go back to reference Feller ER, Schumacher HR (1972) Osteoarticular changes in Wilson’s disease. Arthritis Rheum 15:259–266PubMedCrossRef Feller ER, Schumacher HR (1972) Osteoarticular changes in Wilson’s disease. Arthritis Rheum 15:259–266PubMedCrossRef
17.
go back to reference Aksoy M, Camli N, Dincol K, Erdem S, Akgün T (1972) Osseous changes in Wilson’s disease. A radiologic study of nine patients. Radiology 102:505–509PubMedCrossRef Aksoy M, Camli N, Dincol K, Erdem S, Akgün T (1972) Osseous changes in Wilson’s disease. A radiologic study of nine patients. Radiology 102:505–509PubMedCrossRef
18.
go back to reference Mindelzun R, Elkin M, Scheinberg IH, Sternlieb I (1970) Skeletal changes in Wilson’s disease. A radiological study. Radiology 94:127–132PubMedCrossRef Mindelzun R, Elkin M, Scheinberg IH, Sternlieb I (1970) Skeletal changes in Wilson’s disease. A radiological study. Radiology 94:127–132PubMedCrossRef
20.
go back to reference Rodriges Nieva N, Vernet Bori A (2004) Osteoarthropathy in three siblings with Wilson’s disease. Ann Pediatr (Barc) 61:181–184CrossRef Rodriges Nieva N, Vernet Bori A (2004) Osteoarthropathy in three siblings with Wilson’s disease. Ann Pediatr (Barc) 61:181–184CrossRef
21.
go back to reference Finby N, Bearn AG (1958) Roentgenographic abnormalities of the skeletal system in Wilson’s disease. Am J Roentgenol Radium Ther Nucl Med 79:603–611PubMed Finby N, Bearn AG (1958) Roentgenographic abnormalities of the skeletal system in Wilson’s disease. Am J Roentgenol Radium Ther Nucl Med 79:603–611PubMed
22.
go back to reference Zakraoui L, Amara N, Hamza M, Mrabet A, Hamza M, Hila A, Haddad S (1986) Atteinte articulaire dans la maladie de Wilson. Rev Rhum Mal Osteoartic 53:345–348PubMed Zakraoui L, Amara N, Hamza M, Mrabet A, Hamza M, Hila A, Haddad S (1986) Atteinte articulaire dans la maladie de Wilson. Rev Rhum Mal Osteoartic 53:345–348PubMed
23.
go back to reference Pan HY, Huang CY, Lai CL (1985) Wilson’s disease in a patient presenting with skeletal abnormalities. Orthopedics 8:742–744PubMed Pan HY, Huang CY, Lai CL (1985) Wilson’s disease in a patient presenting with skeletal abnormalities. Orthopedics 8:742–744PubMed
24.
go back to reference Boudin G, Pépin B (1964) Arthropathies dans la maladie de Wilson. Rev Rhum Mal Osteoartic 31:594–598PubMed Boudin G, Pépin B (1964) Arthropathies dans la maladie de Wilson. Rev Rhum Mal Osteoartic 31:594–598PubMed
25.
go back to reference Hegedus D, Ferencz V, Lakatos PL, Meszaros S, Lakatos P, Horvath C, Szalay F (2002) Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease. J Bone Miner Res 17:1961–1967PubMedCrossRef Hegedus D, Ferencz V, Lakatos PL, Meszaros S, Lakatos P, Horvath C, Szalay F (2002) Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease. J Bone Miner Res 17:1961–1967PubMedCrossRef
26.
go back to reference Selimoglu MA, Ertekin V, Doneray H, Yildirim M (2008) Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy. J Clin Gastroenterol 42:194–198PubMedCrossRef Selimoglu MA, Ertekin V, Doneray H, Yildirim M (2008) Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy. J Clin Gastroenterol 42:194–198PubMedCrossRef
27.
go back to reference Cztonkowska A, Tarnaka B, Möller JC, Leinweber B, Bandmann O, Woimant F, Oertel WH (2007) Unified Wilson’s disease Rating Scale—a proposal for the neurological scoring of Wilson’s disease patients. Neurol I Neurochir Pol 41(1):1–2 Cztonkowska A, Tarnaka B, Möller JC, Leinweber B, Bandmann O, Woimant F, Oertel WH (2007) Unified Wilson’s disease Rating Scale—a proposal for the neurological scoring of Wilson’s disease patients. Neurol I Neurochir Pol 41(1):1–2
28.
go back to reference Infante-Rivard C, Esnaola S, Villeneuve JP (1987) Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 7:660–664PubMedCrossRef Infante-Rivard C, Esnaola S, Villeneuve JP (1987) Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 7:660–664PubMedCrossRef
29.
go back to reference Fardellone P, Sebert JL, Bouraya M, Bonidan O, Leclercq G, Doutrellot C, Bellony R, Dubreuil A (1991) Evaluation of the calcium content of diet by frequential self-questionnaire. Rev Rhum Mal Osteoartic 58:99–103PubMed Fardellone P, Sebert JL, Bouraya M, Bonidan O, Leclercq G, Doutrellot C, Bellony R, Dubreuil A (1991) Evaluation of the calcium content of diet by frequential self-questionnaire. Rev Rhum Mal Osteoartic 58:99–103PubMed
30.
go back to reference Fardellone P, Cotté FE, Roux C, Lespessailles E, Mercier F, Gaudin AF (2010) Calcium intake and the risk of osteoporosis and fractures in French women. Joint Bone Spine 77:154–158PubMedCrossRef Fardellone P, Cotté FE, Roux C, Lespessailles E, Mercier F, Gaudin AF (2010) Calcium intake and the risk of osteoporosis and fractures in French women. Joint Bone Spine 77:154–158PubMedCrossRef
31.
go back to reference Epstein S (1988) Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocr Rev 9:437–448PubMedCrossRef Epstein S (1988) Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocr Rev 9:437–448PubMedCrossRef
32.
go back to reference Van Straalen JP, Sanders E, Prummel MF, Sanders GTB (1991) Bone alkaline phosphatase as indicator of bone formation. Clin Chim Acta 201:27–33PubMedCrossRef Van Straalen JP, Sanders E, Prummel MF, Sanders GTB (1991) Bone alkaline phosphatase as indicator of bone formation. Clin Chim Acta 201:27–33PubMedCrossRef
33.
go back to reference Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C (1997) Measurement of bone degradation products in serum using antibodies reactive with an isomerized from of an 8 amino acid sequence of the C-telopeptide of Type I collagen. J Bone Miner Res 12:1028–1034PubMedCrossRef Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C (1997) Measurement of bone degradation products in serum using antibodies reactive with an isomerized from of an 8 amino acid sequence of the C-telopeptide of Type I collagen. J Bone Miner Res 12:1028–1034PubMedCrossRef
34.
go back to reference Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef
35.
go back to reference Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA, Downs RW Jr (2004) International society for clinical densitometry. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 89:3651–3655PubMedCrossRef Lewiecki EM, Watts NB, McClung MR, Petak SM, Bachrach LK, Shepherd JA, Downs RW Jr (2004) International society for clinical densitometry. Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 89:3651–3655PubMedCrossRef
36.
go back to reference Taes Y, Lapauw B, Vanbillemont G, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H, Kaufman JM (2010) Early smoking is associated with peak bone mass and prevalent fractures in young, healthy men. J Bone Miner Res 25(2):379–387PubMedCrossRef Taes Y, Lapauw B, Vanbillemont G, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H, Kaufman JM (2010) Early smoking is associated with peak bone mass and prevalent fractures in young, healthy men. J Bone Miner Res 25(2):379–387PubMedCrossRef
37.
go back to reference Lutsenko S (2008) Atp7b-/- mice as a model for studies of Wilson’s disease. Biomech Soc Trans 36:1233–1238CrossRef Lutsenko S (2008) Atp7b-/- mice as a model for studies of Wilson’s disease. Biomech Soc Trans 36:1233–1238CrossRef
38.
go back to reference Rest JR (1976) The histological effects of copper and zinc on chick embryo skeletal tissues in organ culture. Br J Nutr 36(2):243–254PubMedCrossRef Rest JR (1976) The histological effects of copper and zinc on chick embryo skeletal tissues in organ culture. Br J Nutr 36(2):243–254PubMedCrossRef
39.
go back to reference Li S, Wang M, Chen X, Li SF, Li-Ling J, Xie HQ (2014) Inhibition of osteogenic differentiation of mesenchymal stem cells by copper supplementation. Cell Prolif 47(1):81–90PubMedCrossRef Li S, Wang M, Chen X, Li SF, Li-Ling J, Xie HQ (2014) Inhibition of osteogenic differentiation of mesenchymal stem cells by copper supplementation. Cell Prolif 47(1):81–90PubMedCrossRef
Metadata
Title
Bone status and fractures in 85 adults with Wilson’s disease
Authors
A.-S. Quemeneur
J.-M. Trocello
H.-K. Ea
A. Ostertag
A. Leyendecker
J.-C. Duclos-Vallée
M.-C. de Vernejoul
F. Woimant
F. Lioté
Publication date
01-11-2014
Publisher
Springer London
Published in
Osteoporosis International / Issue 11/2014
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2806-2

Other articles of this Issue 11/2014

Osteoporosis International 11/2014 Go to the issue